SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-001861
Filing Date
2021-01-22
Accepted
2021-01-22 08:05:27
Documents
5
Period of Report
2021-01-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20210122.htm 8-K 39179
2 EX-99.1 life-ex991_6.htm EX-99.1 14637
3 EX-99.2 life-ex992_8.htm EX-99.2 7987
4 GRAPHIC g4zrjatwzrr1000001.jpg GRAPHIC 7594
5 GRAPHIC slide-zmezmumapiy.jpg GRAPHIC 1191346
  Complete submission text file 0001564590-21-001861.txt   1714003
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 21543768
SIC: 2836 Biological Products, (No Diagnostic Substances)